Updates matching "Pain Relief"

Ahead of the President’s State of the Union Address, the American Cancer Society Cancer Action Network (ACS CAN) is calling on the President to emphasize the need for continued bipartisan support for increased federal investment in the fight against cancer.

Washington, D.C.--Today ACS CAN filed comments with the Centers for Disease Control and Prevention regarding proposed clinical practice guidelines for prescribing opioids. Read the full comments

State lawmakers across the country are missing important opportunities to pass and implement proven legislative solutions to prevent and fight cancer, according to a report released today by the American Cancer Society Cancer Action Network (ACS CAN). How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality grades states on the strength of evidence-based policies that help to prevent cancer, which kills roughly 1,670 people a day nationwide, forces patients to pay nearly $4 billion in out-of-pocket expenses every year and in 2015 cost the country more than $80 billion in direct medical expenditures.

Illinois falls short when it comes to implementing policies and passing legislation to help cancer patients manage pain, according to the latest edition of “How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality.” The American Cancer Society Cancer Action Network released the report today.

WASHINGTON, D.C. – Today the Senate Health, Education, Labor and Pensions Committee (HELP) held a hearing on the Opioid Crisis Response Act of 2018. Included in the proposal are several promising provisions that aim to address addiction while maintaining access to necessary relief for individuals fighting pain from cancer and

The Centers for Medicare and Medicaid Services (CMS) released a final Medicare rule yesterday that did not include a proposal that would have set hard limits on opioid pain medication at the pharmacy unless an insurer authorized special permission for a larger dose.